\-\ Texto\\:\\ \ \(0\)\
\-\ ace\\ level\\ \\=\\ 105\\ u\\/l\\ \\(normal\\ 9\\-67\\)\ \(0\)\
\-\ normal\\ physical\\ exam\\ with\\ the\\ exception\\ of\\ the\\ rash\\.\ \(0\)\
\-\ the\\ patient\\ is\\ followed\\ on\\ a\\ routine\\ basis\\ by\\ pulmonology\\ but\\ remains\\ asymptomatic\\.\ \(0\)\
\-\ lymphadenopathy\\ and\\ nodular\\ interstitial\\ opacities\\ with\\ an\\ upper\\ lobe\\ predominance\\.\ \(0\)\
\-\ sarcoidosis\ \(108\)\
\-\ sarcoid\ \(163\)\
\-\ silicosis\\ \ \(1\)\
\-\ lymphangitic\\ carcinomatosis\ \(14\)\
\-\ the\\ patient\\ presented\\ to\\ dermatology\\ with\\ a\\ facial\\ rash\\.\\ after\\ a\\ full\\ work\\-up\\,\\ to\\ include\\ biopsies\\,\\ sarcoidosis\\ was\\ diagnosed\\ and\\ the\\ patient\\ was\\ referred\\ to\\ pulmonology\\ for\\ further\\ evaluation\\.\\ the\\ patient\\ was\\ otherwise\\ asymptomatic\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ pulmonology\\:\\ 0\\.3780893072052911\ \(0\)\
\-\ rash\\:\\ 0\\.3053176895371952\ \(0\)\
\-\ sarcoidosis\\:\\ 0\\.23980627997667187\ \(0\)\
\-\ asymptomatic\\:\\ 0\\.19272708892271936\ \(0\)\
\-\ patient\\:\\ 0\\.18415455567629876\ \(0\)\
\-\ ace\\:\\ 0\\.17050321387391149\ \(0\)\
\-\ exception\\:\\ 0\\.17050321387391149\ \(0\)\
\-\ the\\:\\ 0\\.16946439366842264\ \(0\)\
\-\ silicosis\\:\\ 0\\.16801973468757322\ \(0\)\
\-\ lymphangitic\\:\\ 0\\.16470627570956484\ \(0\)\
\-\ biopsies\\:\\ 0\\.1608811680401199\ \(0\)\
\-\ 105\\:\\ 0\\.1575677090621115\ \(0\)\
\-\ predominance\\:\\ 0\\.15680413858873024\ \(0\)\
\-\ carcinomatosis\\:\\ 0\\.15330340262828407\ \(0\)\
\-\ basis\\:\\ 0\\.1514178820721848\ \(0\)\
\-\ was\\:\\ 0\\.14799321804255802\ \(0\)\
\-\ dermatology\\:\\ 0\\.13850129764436536\ \(0\)\
\-\ opacities\\:\\ 0\\.1351429262877825\ \(0\)\
\-\ remains\\:\\ 0\\.13483079534975706\ \(0\)\
\-\ sarcoid\\:\\ 0\\.13274935329540766\ \(0\)\
\-\ interstitial\\:\\ 0\\.12832046687551688\ \(0\)\
\-\ facial\\:\\ 0\\.11671747914202217\ \(0\)\
\-\ normal\\:\\ 0\\.11558665145740685\ \(0\)\
\-\ lymphadenopathy\\:\\ 0\\.11443411460789786\ \(0\)\
\-\ nodular\\:\\ 0\\.11272211981061574\ \(0\)\
\-\ full\\:\\ 0\\.11064799215053842\ \(0\)\
\-\ routine\\:\\ 0\\.10961631126937736\ \(0\)\
\-\ to\\:\\ 0\\.10616058183192531\ \(0\)\
\-\ referred\\:\\ 0\\.1047391361780888\ \(0\)\
\-\ diagnosed\\:\\ 0\\.10253394868307203\ \(0\)\
\-\ otherwise\\:\\ 0\\.10090085405524794\ \(0\)\
\-\ followed\\:\\ 0\\.09558601612857885\ \(0\)\
\-\ further\\:\\ 0\\.09219294821995822\ \(0\)\
\-\ evaluation\\:\\ 0\\.0863242495173265\ \(0\)\
\-\ level\\:\\ 0\\.08550351749708116\ \(0\)\
\-\ include\\:\\ 0\\.08422010127040146\ \(0\)\
\-\ with\\:\\ 0\\.08315092983831791\ \(0\)\
\-\ presented\\:\\ 0\\.08254309948982572\ \(0\)\
\-\ lobe\\:\\ 0\\.0818001073858795\ \(0\)\
\-\ physical\\:\\ 0\\.07675087569471302\ \(0\)\
\-\ upper\\:\\ 0\\.0756413554300657\ \(0\)\
\-\ exam\\:\\ 0\\.07125561319375039\ \(0\)\
\-\ but\\:\\ 0\\.06999598144803747\ \(0\)\
\-\ after\\:\\ 0\\.0686675242397\ \(0\)\
\-\ by\\:\\ 0\\.060109725738453516\ \(0\)\
\-\ and\\:\\ 0\\.058498551678515635\ \(0\)\
\-\ an\\:\\ 0\\.05412769214535535\ \(0\)\
\-\ for\\:\\ 0\\.042902280564943024\ \(0\)\
\-\ on\\:\\ 0\\.04275009313673044\ \(0\)\
\-\ is\\:\\ 0\\.03876403336408435\ \(0\)\
\-\ of\\:\\ 0\\.027700425615068285\ \(0\)\
